Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 2;9(6):e97384.
doi: 10.1371/journal.pone.0097384. eCollection 2014.

Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes

Ramit Ravona-Springer  1 , Anthony Heymann  2 , James Schmeidler  3 , Erin Moshier  4 , James Godbold  4 , Mary Sano  3 , Derek Leroith  5 , Sterling Johnson  6 , Rachel Preiss  7 , Keren Koifman  1 , Hadas Hoffman  7 , Jeremy M Silverman  3 , Michal Schnaider Beeri  8
Affiliations

Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes

Ramit Ravona-Springer et al. PLoS One. .

Abstract

Objective: To study the relationships of long-term trajectories of glycemic control with cognitive performance in cognitively normal elderly with type 2 diabetes (T2D).

Methods: Subjects (n = 835) pertain to a diabetes registry (DR) established in 1998 with an average of 18 HbA1c measurements per subject, permitting identification of distinctive trajectory groups of HbA1c and examining their association with cognitive function in five domains: episodic memory, semantic categorization, attention/working memory, executive function, and overall cognition. Analyses of covariance compared cognitive function among the trajectory groups adjusting for sociodemographic, cardiovascular, diabetes-related covariates and depression.

Results: Subjects averaged 72.8 years of age. Six trajectories of HbA1c were identified, characterized by HbA1c level at entry into the DR (Higher/Lower), and trend over time (Stable/Decreasing/Increasing). Both groups with a trajectory of decreasing HbA1c levels had high HbA1c levels at entry into the DR (9.2%, 10.7%), and high, though decreasing, HbA1c levels over time. They had the worst cognitive performance, particularly in overall cognition (p<0.02) and semantic categorization (p<0.01), followed by that of subjects whose HbA1c at entry into the DR was relatively high (7.2%, 7.8%) and increased over time. Subjects with stable HbA1c over time had the lowest HbA1c levels at entry (6.0%, 6.8%) and performed best in cognitive tests.

Conclusion: Glycemic control trajectories, which better reflect chronicity of T2D than a single HbA1c measurement, predict cognitive performance. A trajectory of stable HbA1c levels over time is associated with better cognitive function.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Trajectories in HbA1c levels.
Groups: 1 = lower Stable, 2 = Higher Stable, 3 = Lower Increasing, 4 = Higher Increasing, 5 = Lower Decreasing, 6 = Higher Decreasing.
Figure 2
Figure 2. Study flow chart.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, et al. (2010) Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 75: 1195–1202. - PubMed
    1. Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, et al. (2004) Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 63: 1902–1907. - PubMed
    1. Mokini Z, Chiarelli F (2006) The molecular basis of diabetic microangiopathy. Pediatr Endocrinol Rev 4: 138–152. - PubMed
    1. Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, et al. (2008) Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 31 Suppl 2S155–160. - PubMed
    1. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, et al. (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353: 2643–2653. - PMC - PubMed

Publication types

Substances